[The evaluation of adaptive possibilities of organism under therapy of diabetes mellitus type I and II.]
The article presents results of the study of electrophoretic agility of erythrocytes, their pro-oxidant characteristics and intra-cellular concentration of adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (2,3-DPG) in patients with diabetes mellitus type I and II under implementation of therapy. The sampling included 46 patients with diabetes mellitus type I and II. The control group consisted of 22 healthy volunteers. 20 patients with diabetes mellitus type i received insulin protaphan and insulin actrapid, 26 patients with diabetes mellitus type II received preparations of sulfanylurea, biguanides, incretins. The analysis of blood was applied before and after course of treatment. The electrophoretic agility of erythrocytes was analyzed, including concentration of malonic dialdehyde in them, content of 2,3-DPG and ATP. In case of diabetes mellitus type I and II, the study established increasing of content of malonic dialdehyde, decreasing of electrophoretic agility of erythrocytes, concentration of ATP and 2,3-DPG in erythrocytes concerning physiological standard, mostly expressed in patients with diabetes mellitus type I. The therapy decreased concentration of malonic dialdehyde and increased electrophoretic agility of erythrocytes, content of ATP and 2,3-DPG as compared with indices before treatment. In patients with diabetes mellitus type II during treatment reduction of electrophoretic agility of erythrocytes and 2,3-DPG up to physiological standard was observed. The positive effect of the given clinical strategies during treatment of diabetes mellitus type I and II is conditioned by decreasing of stress reaction and activation of adaptation processes that is manifested at the level of micro-circulation by amelioration of oxygen-transport function of blood at the expense of increasing of electrophoretic agility of erythrocytes, level of 2,3-DPG and decreasing of destructive processes of membranes of erythrocytes.